DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of beta-amyloid (Abeta).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimers disease.
Molekulargewicht:
367.87
Reinheit:
>99.99%
CAS Nummer:
[883027-32-5]
Formel:
C16H14ClNO3S2
Target-Kategorie:
Beta Amyloid|||BACE|||CDK
T61439
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten